What is the main business of NDG People?

The main business activity of NDG People focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 1, 2008.

Where is the headquarters located?

The headquarters is located at: ul. Limbowa 1, 10-163 Olsztyn.

What is the share capital?

The share capital of the company is PLN 1,230,000 (approx. $332,253).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $1,148,913 in 2024, which is an increase of 182.0% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $114,712.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $664,695 in 2024, representing 65% of all operating expenses.

NDG Peoplesp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2008-10-01

Share capital

1 230 000,00 PLN

Registered address

ul. Limbowa 1, 10-163 Olsztyn, Poland

Electronic delivery address

AE:PL-91098-54684-RIGII-15

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 1.15mMedianUSD 873.84kAverageUSD 20.03m

Net profit

This companyUSD 114.71kMedianUSD 28.21kAverageUSD 815.54k

Operating costs

This companyUSD 1.02mMedianUSD 801.08kAverageUSD 18.78m

Assets

This companyUSD 375.36kMedianUSD 539.29kAverageUSD 10.66m

Industry

Bank accounts

Registered as a VAT taxpayer on 2008-11-01. Active

mBank
77 1140 1111 0000 4014 9400 1002

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
May 18, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$30,241	Polski Fundusz Rozwoju S.A.

Tenders

No recorded participation in tenders.

Authorized Representatives

Jarosław Janiszewski — President of the Management Board

Manner of representation

Each member of the management board is independently authorized to make declarations of will on behalf of the company, or an independent commercial proxy.

Ownership

Owner	Shares	Share value	Stake
NDG Medical sp. z o.o.	2,360	$318,746.62	95.935%
Others	100	$13,506.21	4.065%

Beneficial owners

Person	Rights
Jan Wiktor Czochara (31)	Shareholder of a limited liability company, 1081667.0 PLN

Competitors

Name	Revenue	Website
OwlieS.A.	$17,199,251.89	owlie.pl
Medimessp. z o.o.	$1,228,073.80	medimes.pl
Optimed Pro-Office Cirrosp. j.	$1,276,876.90	cirro.pl
Sonomedical Pluciński, Wojciechowski, Wituskisp. j.	$1,264,523.63	sonomedical.pl
Medpipesp. z o.o.	$1,191,948.44	medpipe.pl
Cytogen - Polskasp. z o.o.	$1,127,200.51	cytogen.com.pl
Zbadajsiesp. z o.o.	$1,112,372.08	labhome.pl
Medaidsp. z o.o.	$1,034,514.88	medaid.pl
Polcoresp. z o.o.	$1,015,341.48	polcore.pl
Surgical Solutionssp. z o.o.	$947,852.75	surgical-solutions.pl

Change history

Date	Event
2017-03-01	Address change (Ul. Lubelska 32e, 10-409, Olsztyn → Ul. Limbowa 1, 10-163, Olsztyn)
2016-02-15	Name change (Infarmacja → Ndg People)
2015-03-27	Address change (Jeziorańska 16, 11-040, Dobre Miasto → Ul. Lubelska 32e, 10-409, Olsztyn)
2015-02-12	PKD change (Removed: 20.42.Z, 46.18.Z, 46.19.Z, 47.74.Z, 47.75.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 70.21.Z, 70.22.Z, 73.11.Z, 73.12.C, 73.20.Z, 74.90.Z, 77.11.Z, 77.12.Z, 77.40.Z, 78.10.Z, 78.20.Z, 82.30.Z, 85.32.A, 85.59.B)
2014-02-12	Share capital change (50,000.00 PLN → 1,230,000.00 PLN)

FAQ

Last updated: 2026-04-16